Pacira BioSciences, Inc. Quarterly Debt-to-equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Pacira BioSciences, Inc. quarterly Debt-to-equity history and growth rate from Q1 2012 to Q3 2024.
  • Pacira BioSciences, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 86.6 %, a 11.1% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 86.6 -10.8 -11.1% Sep 30, 2024
Q2 2024 82.5 -25.1 -23.4% Jun 30, 2024
Q1 2024 83.3 -34.1 -29.1% Mar 31, 2024
Q4 2023 88.4 -45.4 -33.9% Dec 31, 2023
Q3 2023 97.4 -53.3 -35.4% Sep 30, 2023
Q2 2023 108 -34.4 -24.2% Jun 30, 2023
Q1 2023 117 -16.3 -12.2% Mar 31, 2023
Q4 2022 134 +16.9 +14.5% Dec 31, 2022
Q3 2022 151 +54.7 +57% Sep 30, 2022
Q2 2022 142 +41.2 +40.8% Jun 30, 2022
Q1 2022 134 +26.4 +24.6% Mar 31, 2022
Q4 2021 117 +4.22 +3.75% Dec 31, 2021
Q3 2021 95.9 -23.8 -19.9% Sep 30, 2021
Q2 2021 101 -26.4 -20.7% Jun 30, 2021
Q1 2021 107 -22 -17% Mar 31, 2021
Q4 2020 113 -16.9 -13% Dec 31, 2020
Q3 2020 120 -5.05 -4.05% Sep 30, 2020
Q2 2020 127 +6.23 +5.15% Jun 30, 2020
Q1 2020 129 +10.8 +9.08% Mar 31, 2020
Q4 2019 130 +10.3 +8.59% Dec 31, 2019
Q3 2019 125 +2.78 +2.28% Sep 30, 2019
Q2 2019 121 -3.42 -2.75% Jun 30, 2019
Q1 2019 118 -8.7 -6.84% Mar 31, 2019
Q4 2018 119 -7.48 -5.9% Dec 31, 2018
Q3 2018 122 +4.99 +4.27% Sep 30, 2018
Q2 2018 124 +19.4 +18.5% Jun 30, 2018
Q1 2018 127 +36.9 +40.9% Mar 31, 2018
Q4 2017 127 +50.5 +66.3% Dec 31, 2017
Q3 2017 117 +41 +54% Sep 30, 2017
Q2 2017 105 +29.5 +39% Jun 30, 2017
Q1 2017 90.2 +13.2 +17.1% Mar 31, 2017
Q4 2016 76.3 -3.08 -3.88% Dec 31, 2016
Q3 2016 76 -6.43 -7.81% Sep 30, 2016
Q2 2016 75.6 -11.7 -13.4% Jun 30, 2016
Q1 2016 77.1 -14.2 -15.5% Mar 31, 2016
Q4 2015 79.3 -33.9 -29.9% Dec 31, 2015
Q3 2015 82.4 -62.6 -43.2% Sep 30, 2015
Q2 2015 87.3 -104 -54.3% Jun 30, 2015
Q1 2015 91.2 -178 -66.2% Mar 31, 2015
Q4 2014 113 -109 -49% Dec 31, 2014
Q3 2014 145 -20.7 -12.5% Sep 30, 2014
Q2 2014 191 +70.1 +57.9% Jun 30, 2014
Q1 2014 269 +185 +219% Mar 31, 2014
Q4 2013 222 +149 +202% Dec 31, 2013
Q3 2013 166 +80.1 +93.6% Sep 30, 2013
Q2 2013 121 +0.25 +0.21% Jun 30, 2013
Q1 2013 84.5 -120 -58.7% Mar 31, 2013
Q4 2012 73.4 Dec 31, 2012
Q3 2012 85.6 Sep 30, 2012
Q2 2012 121 Jun 30, 2012
Q1 2012 204 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.